Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
Year: 2020
Type: article
Abstract: Prior studies with the use of a prospective–retrospective design including archival tumor samples have shown that gene-expression assays provide clinically useful prognostic information. However, a prospectively conducted study in a uniformly treated population provides the highest level of evidence supporting the clinical validity and usefulness of a biomarker.
Source: UNC Libraries
DOI: 10.17615/6e7v-pv95
Authors: Wood, William C., Lively, Tracy, Olson, John A., Gray, Robert J., Kaklamani, Virginia G., Makower, Della F., Wagner, Lynne I., Gomez Moreno, Henry L., Dees, Elizabeth C., Mayer, Ingrid A., Paik, Soonmyung, Pritchard, Kathleen I., Albain, Kathy S., Ellis, Matthew J., Sparano, Joseph A., Hayes, Daniel F., Goggins, Timothy F., Saphner, Thomas J., Perez, Edith A., Sledge, George W., Badve, Sunil S., Geyer, Charles E., Brufsky, Adam M., Zujewski, JoAnne, Ravdin, Peter, Reddy, Pavan S., Keane, Maccon M., Toppmeyer, Deborah L., Berenberg, Jeffrey L., Atkins, James N., Whelan, Timothy J.
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
Funders: American College of Radiology Imaging Network, Vanderbilt University, Emory University, Northwestern University, Wake Forest University, Johns Hopkins University, University of Pittsburgh, Virginia Commonwealth University, Sunnybrook Research Institute, ECOG-ACRIN Cancer Research Group, Yonsei University, National Institutes of Health, University of North Carolina at Chapel Hill, School of Medicine, Indiana University, School of Medicine, Virginia Commonwealth University, Yonsei University College of Medicine, National Cancer Institute
OpenAlex ID: W4299569507